Drugdiscovery >> Clinical Trials >> News
3122
Views
New MRSA drug is going to be developed - drugdiscovery.com
New MRSA drug is going to be developed - drugdiscovery.com


Potential MRSA treatment drug is going to be developed. EDP-788 is in phase I clinical trial. Enanta Pharmaceuticals has enrolled 64 healthy men and women.
Read More >>


Tags: Enanta Pharmaceuticals, EDP-788, clinical trial, mrsa - January 29, 2014
Related Articles
5356
Views
New Alzheimer drug enters Phase 3 program New Alzheimer drug enters Phase 3 program
Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different Read More >>

Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial

21001
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

1601
Views
Phase III trial of Amgen's drug was an outstanding success Phase III trial of Amgen's drug was an outstanding success
Evolocumab, the new drug of Amgen has gone through Phase III. clinical trial. The result is a statistically significant reduction in low-density lipoprotein cholesterol. The new drug seems to be 66% m Read More >>

Tags: drug, competitior, cholesterol, Amgen

4903
Views
Theravance’s experimental COPD drug meets study goal Theravance’s experimental COPD drug meets study goal
Theravance announced that the drug, named TD-408, taken as a once-per-day treatment for moderate to severe chronic obstructive pulmonary disease met its goals in a midstage clinical trial. Read More >>

Tags: Theravance, experimental drug, COPD, lung disease, clinical trial

5994
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

6296
Views
Boehringer Ingelheim’s  COPD drug successful in  Phase 3 studies Boehringer Ingelheim’s COPD drug successful in Phase 3 studies
The results show that olodaterol Respimat, in addition to usual care, provides statistically significant improvements in lung function in patients with COPD, compared to usual care alone. Read More >>

Tags: olodaterol Respimat, COPD, drug, new treatment, Boehringer Ingelheim, Boehringer, clinical trial

16290
Views
Novel brain cancer drug proceeds to the Phase II clinical trial Novel brain cancer drug proceeds to the Phase II clinical trial
The major obstacle for the treatment of malignant brain diseases is the protective blood-brain barrier (BBB), which restricts drug delivery into the central nervous system. To circumvent this issue, a Read More >>

Tags: blood-brain barrier, brain tumor, brain cancer, drug delivery, doxorubicin, G-Technology, liposome

8399
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

4111
Views
'Double Chin' drug successful in two late-stage clinical studies 'Double Chin' drug successful in two late-stage clinical studies
Kythera Biopharmaceuticals’ drug, ATX-101, which is used for reducing fat in the submental area of the neck, reached its main and secondary goals in late stage clinical trials. Read More >>

Tags: Kythera, double chin, new drug, clinical trials, ATX-101

4180
Views
GSK has ended the trials of its new lung cancer treatment GSK has ended the trials of its new lung cancer treatment
Phase 3 trial of its MAGE-A3 was reported to be finished by GlaxoSmithKline. They say it is impossible to make sure that the drug is effective against non-small-cell lung cancer. Read More >>

Tags: GSK clinical trial., MAGE-A3, lung cancer, lung cancer drug, lung cancer drug development

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013